[1]赖 超,成官迅.rs-fMRI、DTI及1H-MRS在阿尔茨海默病中的应用进展[J].医学信息,2018,31(13):41-44.[doi:10.3969/j.issn.1006-1959.2018.13.013]
　LAI Chao,CHENG Guan-xun.Application of rs-fMRI、DTI and 1H-MRS in Alzheimer’s Disease[J].Journal of Medical Information,2018,31(13):41-44.[doi:10.3969/j.issn.1006-1959.2018.13.013]
点击复制

rs-fMRI、DTI及1H-MRS在阿尔茨海默病中的应用进展()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年13期
页码:
41-44
栏目:
综述
出版日期:
2018-07-01

文章信息/Info

Title:
Application of rs-fMRI、DTI and 1H-MRS in Alzheimer’s Disease
文章编号:
1006-1959（2018）13-0041-04
作者:
赖 超; 成官迅
北京大学深圳医院医学影像科，广东 深圳 518036
Author(s):
LAI Chao; CHENG Guan-xun
Department of Medical Imaging,Shenzhen Hospital of Peking University,Shenzhen 518036,Guangdong,China
关键词:
阿尔茨海默病; 轻度认知功能障碍; 功能磁共振; 弥散张量成像; 磁共振波谱
Keywords:
Key words:Alzheimer's disease; Mild cognitive impairment; Diffusion tensor imaging
分类号:
R749.16
DOI:
10.3969/j.issn.1006-1959.2018.13.013
文献标志码:
A
摘要:
随着磁共振成像技术的飞速发展，对阿尔茨海默病的神经影像学研究也越来越深入。其主要目的是通过磁共振影像学特征来识别出早期阿尔茨海默病患者，从而达到早期诊断和治疗的目的。本文就磁共振成像技术包括静息态功能磁共振成像、弥散张量成像及磁共振波谱在阿尔茨海默病的应用进展进行综述。
Abstract:
Abstract:With the rapid development of magnetic resonance imaging technology, neuro imaging research on Alzheimer’s disease is becoming more and more in-depth.Its main purpose is to identify early Alzheimer’s disease patients by magnetic resonance imaging (MRI) features,so as to achieve early diagnosis and treatment.This paper reviews the applications of magnetic resonance imaging techniques including resting functional magnetic resonance imaging,diffusion tensor imaging and magnetic resonance spectroscopy in Alzheimer’s disease.

参考文献/References:

[1]Sohrabi HR,Weinborn M,Badcock J,et al.New lexicon and criteria for the diagnosis of Alzheimer's disease[J].Lancet Neurol,2011,10(4):299-300. [2]Cha J,Hwang JM,Jo HJ,et al.Assessment of FunctionalCharacteristics of Amnestic Mild Cognitive Impairment and Alzheimer's Disease Using Various Methods of Resting-State FMRI Analysis[J].Biomed Research International,2014,2014(7459):1-12. [3]Li HJ,Hou XH,Liu HH,et al.Toward systems neuroscience in mild cognitive impairment and Alzheimer's disease:a meta-analysis of 75 fMRI studies[J].Human Brain Mapping,2015,36 (3):1217. [4]Griffanti L,Dipasquale O,Laganà MM,et al.Effective artifact removal in resting state fMRI data improves detection of DMN functional connectivity alteration in Alzheimer's disease[J].Frontiers in Human Neuroscience,2015,9(449):449. [5]Zhong Y,Huang L,Cai S,et al.Altered effective connectivity patterns of the default mode network in Alzheimer's disease:an fMRI study[J].Neuroscience Letters,2014(578):171-175. [6]Wang Z,Wang J,Zhang H,et al.Interhemispheric Functional and Structural Disconnection in Alzheimer's Disease:A Combined Resting-State fMRI and DTI Study[J].Plos One,2015,10(5):e0126310. [7]Balachandar R,John JP,Saini J,et al.A study of structural and functional connectivity in early Alzheimer's disease using rest fMRI and diffusion tensor imaging[J].International Journal of Geriatric Psychiatry,2015,30(5):497-504. [8]Khazaee A,Ebrahimzadeh A,Babajani-Feremi A.Identifying patients with Alzheimer's disease using resting-state fMRI and graph theory[J].Clinical Neurophysiology,2015,126(11):2132-2141. [9]席芊,赵小虎,王培军,等.轻度阿尔茨海默病患者静息态脑默认活动网络的fMRI研究[J].中华神经医学杂志,2012,11(6):609-612. [10]姚洪祥,安宁豫,张熙,等.遗忘型轻度认知障碍杏仁核功能连接静息态纵向变化功能磁共振研究[J]. 放射学实践,2014,29(06):613-617. [11]Lacalle-Aurioles M,Navas-Sánchez FJ,Alemán-Gómez Y,et al.The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural,Perfusion,and Diffusion Tensor Imaging[J].Journal of Alzheimer's Disease Jad ,2016,50(4):S20-S21. [12]Bozoki AC,Korolev IO,Davis NC,et al.Disruption of limbic white matter pathways inmild cognitive impairment and Alzheimer'sdisease:a DTI FDG-PET study[J].Human Brain Mapping,2012,33(8):1792. [13]Jahng GH,Xu S,Weiner MW,et al.DTI studies in patients with Alzheimer's disease,mild cognitive impairment,or normal cognition with evaluation of the intrinsic background gradients[J].Neuroradiology,2011,53(10):749. [14]Soldner J,Meindl T,Koch W,et al.Structural and functional neuronal connectivity in Alzheimer's disease:a combined DTI and fMRI study[J].Der Nervenarzt,2012,83(7):878-887. [15]孟京志,皇丽丽,郭李炜,等.阿尔茨海默病患者联络纤维的DTI诊断价值[J].临床放射学杂志,2012,31(2):158-162. [16]王珲,唐荣华,朱文珍,等.阿尔茨海默病额叶白质损害的DTI与临床执行功能的关系[J].中国神经精神疾病杂志,2009,35(10):586-589. [17]郭龙军,李坤成,陈忠伟.磁共振检查技术DTI在阿尔茨海默病与轻度认知障碍中的应用[J].中国CT和MRI杂志,2015,13(11):1-3. [18]Kantarci K,Weigand SD,Petersen RC,et al.Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease[J].Neurobiology of Aging,2007,28(9):1330-1339. [19]Guo Z,Liu X,Hou H,et al.1H -MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease[J].Comprehensive Psychiatry,2016(69):179. [20]Henigsberg N,Kalember P,Hraba P, et al.1H-MRS changes in dorsolateral prefrontal cortex after donepezil treatment in patients with mild to moderate Alzheimer's disease[J].Collegium Antropologicum,2011,35 (Suppl) 1:159-162.

相似文献/References:

[1]刘 璐,秦新月.阿尔茨海默病患者血尿酸水平变化的研究[J].医学信息,2018,31(02):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
　LIU Lu,QIN Xin-yue.Study on the Changes of Serum Uric Acid in Alzheimer 's Disease Patients[J].Journal of Medical Information,2018,31(13):96.[doi:10.3969/j.issn.1006-1959.2018.02.033]
[2]刘 波,罗文静,张 翼,等.血清脂联素水平与轻度认知功能障碍的相关性研究[J].医学信息,2018,31(10):7.[doi:10.3969/j.issn.1006-1959.2018.10.003]
　LIU Bo,LUO Wen-jing,ZHANG Yi,et al.Correlation between Serum Adiponectin Level and Mild Cognitive Impairment[J].Journal of Medical Information,2018,31(13):7.[doi:10.3969/j.issn.1006-1959.2018.10.003]
[3]唐娟娟,高春岭,秦凤琴.蒙特利尔认知评估量表在成都市郫都区老年性痴呆筛查中的应用分析[J].医学信息,2018,31(19):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
　TANG Juan-juan,GAO Chun-ling,QIN Feng-qin.Application Analysis of Montreal Cognitive Assessment Scale in Screening for Alzheimer’s Disease in Pidu District,Chengdu[J].Journal of Medical Information,2018,31(13):12.[doi:10.3969/j.issn.1006-1959.2018.19.004]
[4]张 辉,张 颖.多奈哌齐联合司来吉兰对阿尔茨海默病患者认知功能及不良反应的影响[J].医学信息,2022,35(13):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
　ZHANG Hui,ZHANG Ying.Effect of Donepezil Combined with Selegilan on Cognitive Function and Adverse Reactions in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2022,35(13):110.[doi:10.3969/j.issn.1006-1959.2022.13.024]
[5]杨联勇,沈金娥.阿尔茨海默病新药的临床实验研究[J].医学信息,2020,33(02):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
　YANG Lian-yong,SHEN Jin-e.Clinical Experimental Study of New Drugs for Alzheimer’s Disease[J].Journal of Medical Information,2020,33(13):50.[doi:10.3969/j.issn.1006-1959.2020.02.014]
[6]康晨瑶,刘 洲,周海红.NLRP3炎症小体在AD发病机制中的作用[J].医学信息,2021,34(12):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
　KANG Chen-yao,LIU Zhou,ZHOU Hai-hong.The Role of NLRP3 Inflammasome in the Pathogenesis of AD[J].Journal of Medical Information,2021,34(13):40.[doi:10.3969/j.issn.1006-1959.2021.12.011]
[7]韦春英,莫颖敏.阿尔茨海默病早期诊断的脑脊液和血液生物标志物研究[J].医学信息,2021,34(14):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
　WEI Chun-ying,MO Ying-min.Study on Cerebrospinal Fluid and Blood Biomarkers for Early Diagnosis of Alzheimer’s Disease[J].Journal of Medical Information,2021,34(13):25.[doi:10.3969/j.issn.1006-1959.2021.14.007]
[8]于京虎.复方脑肽节苷脂联合多奈哌齐对阿尔茨海默病患者认知功能及SOD水平的影响[J].医学信息,2023,36(03):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]
　YU Jing-hu.Effect of Compound Porcine Cerebroside and Ganglioside Combined with Donepezil on Cognitive Function and SOD Level in Patients with Alzheimer’s Disease[J].Journal of Medical Information,2023,36(13):148.[doi:10.3969/j.issn.1006-1959.2023.03.031]
[9]张 瑞,延沁儒.丹酚酸B调节Bax/Bcl-2的表达对阿尔茨海默病小鼠认知功能的影响及机制[J].医学信息,2021,34(17):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
　ZHANG Rui,YAN Qin-ru.Effects of Salvianolic Acid B on the Cognitive Function of Alzheimer’s Disease Mice and its Mechanism Regulating the Expression of Bax/Bcl-2[J].Journal of Medical Information,2021,34(13):70.[doi:10.3969/j.issn.1006-1959.2021.17.018]
[10]徐 静.综合康复护理对阿尔兹海默病患者认知功能及生活能力的影响[J].医学信息,2023,36(04):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]
　XU Jing.Effect of Comprehensive Rehabilitation Nursing on Cognitive Function and Living Ability of Patients with Alzheimer’s Disease[J].Journal of Medical Information,2023,36(13):150.[doi:10.3969/j.issn.1006-1959.2023.04.031]

更新日期/Last Update: 2018-07-01